Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+8975Peak area normalizedmale diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+11936Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+13187Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+13203Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+31658Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+37163Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+41518Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+42503Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+46115Peak area normalizedmale diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+47551Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+49613Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+50586Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+54751Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODE1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID (M+H)+Peak area normalizedfemale diabetic Neuropathy

Return to search page
  logo